ijms-logo

Journal Browser

Journal Browser

Biomaterials for Tissue Regeneration: Current Progress and Future Directions

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Materials Science".

Deadline for manuscript submissions: closed (20 November 2025) | Viewed by 3204

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Titu Maiorescu University, 031593 Bucharest, Romania
2. Department of Oral and Maxillofacial Surgery, Carol Davila Central Military Emergency Hospital, 010825 Bucharest, Romania
Interests: head and neck cancer; prognostic biomarkers; carcinogenesis; imaging; inflammation; salivary
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. European Centre of Oral Implantology, 011473 Bucharest, Romania
2. Oral Implantology Department, Faculty of Dental Medicine, Titu Maiorescu University, 031593 Bucharest, Romania
Interests: implantology; oral rehabilitation; biomaterials

Special Issue Information

Dear Colleagues,

Hard and soft tissue defects can arise from various causes, including congenital anomalies, trauma, tumor resection, and surgical interventions. Currently available reconstruction techniques have significant limitations, especially in large, composite defects. Often, in restorative medicine, clinicians face unique challenges due to the complex anatomy and the need to rehabilitate both the anatomy and the functionality, providing an adequate quality of life and social reintegration for the patients. A multidisciplinary approach to ensure a comprehensive evaluation and customized treatment planning to address individual patient needs is a key element for successful reconstruction. A wide range of biomaterials and, more recently, 3D bioprinting have been implemented and become crucial elements for successful reconstructions, serving as scaffolds for tissue regeneration or as implants to restore structural integrity. Tissue engineering approaches involving stem cells, growth factors, and bioactive scaffolds hold promise for enhancing tissue regeneration and improving long-term outcomes. These constructs elicit a complex biological response upon implantation. Various tangled signaling mechanisms orchestrate cellular activities, essential for tissue repair and regeneration. Different types of cells interact with biomaterials to influence the healing process. Surface properties, such as topography and chemistry, modulate cell adhesion, proliferation, and differentiation. Understanding these molecular mechanisms enables tailoring specific regenerative applications in the reconstruction of complex tissue defects.

In this Special Issue, we invite contributions that shed light on the molecular mechanisms involved in the successful reconstruction of soft and hard tissue defects. Researchers are encouraged to submit manuscripts presenting original research findings, review papers, innovative methodologies, and conceptual advances aiming to investigate and deepen the understanding of the molecular features that support an optimal restorative model.

Prof. Dr. Ana Caruntu
Prof. Dr. Horia Barbu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • biomaterials
  • biocompatibility
  • tissue engineering
  • tissue defect
  • rehabilitation
  • scaffolds
  • regenerative medicine
  • angiogenesis
  • stem cells
  • antimicrobial

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

20 pages, 10661 KB  
Article
A New Approach for Orbital Wall Reconstruction in a Rabbit Animal Model Using a Hybrid Hydroxyapatite–Collagen-Based Implant
by Victor A. Vasile, Sinziana Istrate, Laura-Madalina Cursaru, Roxana M. Piticescu, Aurelian M. Ghita, Diana M. Popescu, Gerhard Garhöfer, Ana M. Catrina, Sonia Spandole-Dinu, Cerasela Haidoiu, Vladimir Suhaianu, Oana C. Voinea, Dumitru Valentin Dragut and Alina Popa-Cherecheanu
Int. J. Mol. Sci. 2024, 25(23), 12712; https://doi.org/10.3390/ijms252312712 - 26 Nov 2024
Viewed by 1409
Abstract
Reconstructing the orbit following complex craniofacial fractures presents significant challenges. Throughout the years, several materials have been used for orbital reconstruction, taking into account factors such as their durability, compatibility with living tissue, cost efficiency, safety, and capacity to be adjusted during surgery. [...] Read more.
Reconstructing the orbit following complex craniofacial fractures presents significant challenges. Throughout the years, several materials have been used for orbital reconstruction, taking into account factors such as their durability, compatibility with living tissue, cost efficiency, safety, and capacity to be adjusted during surgery. Nevertheless, a consensus has not yet been reached on the optimal material for orbital restoration. This study investigates the potential of a hybrid hydroxyapatite–collagen (HAp-COL) material 3D-printed on Ti mesh to be used as an implant for orbital wall reconstruction. HAp-COL powder was synthesized using a high-pressure hydrothermal technique. The powder was further used to 3D-print HAp-COL structures on titanium mesh, with the latter having potential uses in orbital wall reconstruction. Biocompatibility was assessed by evaluating the effects of the HAp-COL material on the adhesion and proliferation of fibroblasts (3T3) and mesenchymal stem cells (MSCs) in culture. In vitro and in vivo results showed that HAp-COL is highly biocompatible and has a good integration of the implant in the bone. The findings reported in this study offer convincing evidence to support the use of our designed HAp-COL for the restoration of orbital wall fractures, with a high level of safety. Full article
Show Figures

Figure 1

Review

Jump to: Research

28 pages, 4327 KB  
Review
Optimizing rhBMP-2 Therapy for Bone Regeneration: From Safety Concerns to Biomaterial-Guided Delivery Systems
by Maria Chernysheva, Evgenii Ruchko and Artem Eremeev
Int. J. Mol. Sci. 2025, 26(21), 10723; https://doi.org/10.3390/ijms262110723 - 4 Nov 2025
Viewed by 1142
Abstract
Reconstruction of large and complex hard tissue defects remains a major clinical challenge, as conventional autografts and allografts are often limited in availability, biological compatibility, and long-term efficacy, particularly for extensive defects or poor bone quality. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is [...] Read more.
Reconstruction of large and complex hard tissue defects remains a major clinical challenge, as conventional autografts and allografts are often limited in availability, biological compatibility, and long-term efficacy, particularly for extensive defects or poor bone quality. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a potent osteoinductive factor capable of initiating the complete cascade of bone formation. However, its clinical use is restricted by dose-dependent complications such as inflammation, ectopic ossification, and osteolysis. This review synthesizes current evidence on the safety profile of rhBMP-2 and examines strategies to enhance its therapeutic index. Preclinical and clinical data indicate that conventional collagen-based carriers frequently cause rapid burst release and uncontrolled diffusion, aggravating adverse outcomes. It is noteworthy that low doses of rhBMP-2 (0.5–0.7 mg/level in anterior cervical discectomy and fusion (ACDF) or 0.5–1.0 mg/level in transforaminal lumbar interbody fusion (TLIF)) provide the optimal balance of efficacy and safety. Advanced biomaterial-based platforms, such as bioceramic–polymer composites, injectable hydrogels, and 3D-printed scaffolds, enable spatially and temporally controlled release while maintaining osteogenic efficacy. Molecular delivery approaches, including chemically modified messenger RNA (cmRNA) and regional gene therapy, provide transient, site-specific rhBMP-2 expression with reduced dosing and minimal systemic exposure. By integrating mechanistic insights with translational advances, this review outlines a framework for optimizing rhBMP-2-based regenerative protocols, emphasizing their potential role in multidisciplinary strategies for reconstructing complex hard tissue defects. Full article
Show Figures

Figure 1

Back to TopTop